Our Health Care Litigation Team discusses a District of Massachusetts case holding that allows the government to switch liability theories in its False Claims Act lawsuit against Regeneron Pharmaceuticals....more
8/11/2025
/ Anti-Kickback Statute ,
Department of Justice (DOJ) ,
Discovery ,
False Claims Act (FCA) ,
Healthcare Fraud ,
Litigation Strategies ,
Medicare ,
Pharmaceutical Industry ,
Popular ,
Regeneron ,
Summary Judgment
Welcome back to the Class Action & MDL Roundup! This year has begun with cases all over the map, from California to Florida to Massachusetts.
The West Coast features overbearing manufacturers, allegedly underpaid lenders,...more
4/5/2019
/ Antitrust Litigation ,
Banking Sector ,
Biometric Information ,
Class Action ,
Class Certification ,
Data Collection ,
Employee Retirement Income Security Act (ERISA) ,
Facebook ,
FDCPA ,
Mortgage Lenders ,
Multidistrict Litigation ,
Pharmaceutical Industry ,
Popular ,
Prescription Drugs ,
Putative Class Actions ,
Remand
Where the (Class) Action Is -
Welcome to 2018 and the latest edition of Roundup covering significant decisions and settlements from the last quarter of 2017. On the docket this quarter is another slate of cases covering a...more
3/7/2018
/ Antitrust Litigation ,
Article III ,
Automotive Industry ,
Biometric Information Privacy Act ,
Class Action ,
Class Certification ,
Corporate Counsel ,
Employment Litigation ,
False Advertising ,
FRCP 23 ,
GMO ,
Motion to Dismiss ,
Pharmaceutical Industry ,
Phishing Scams ,
Retirement Plan ,
Standing ,
Student Athletes ,
TCPA ,
Unsolicited Faxes ,
Wage and Hour ,
Young Lawyers